Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannabis with tetrahydrocannabinol without cannabidiol-University College, London
- Development stage
- Unknown
- Lead developer
- University College London
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
Cannabis with tetrahydrocannabinol without cannabidiol is a specific research formulation of vaporised cannabis flower containing delta-9-tetrahydrocannabinol (THC) but lacking cannabidiol (CBD). It was developed and utilized by University College London (UCL) for the CannTeenA study (2019-2021) to investigate the acute subjective, behavioral, and neural effects of THC in isolation, specifically comparing responses between adolescents and adults. THC acts as a partial agonist at the Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2) within the endocannabinoid system. By excluding CBD, which is thought to modulate some of THC's effects, researchers aimed to better understand the specific risks of high-THC cannabis on memory, reward processing, and the induction of psychotic-like symptoms.
- Other names
- THC-only cannabisvaporised cannabis with THC without CBDdelta-9-tetrahydrocannabinoldelta9-tetrahydrocannabinoldelta 9-tetrahydrocannabinol
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on cannabis with tetrahydrocannabinol without cannabidiol-University College, London.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannabis with tetrahydrocannabinol without cannabidiol-University College, London.